Cantor Fitzgerald Starts StemCells (STEM) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $4.19 -6.26%
Rating Summary:
9 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 18 | New: 34
Rating Summary:
9 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 18 | New: 34
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on StemCells (NASDAQ: STEM) with a Buy rating and a price target of $2.00.
For an analyst ratings summary and ratings history on StemCells click here. For more ratings news on StemCells click here.
Shares of StemCells closed at $0.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Starts Centrus Energy Corp. (LEU) at Buy
- JPMorgan Starts Travel + Leisure (TNL) at Neutral
- Erste Group Starts SpaceX (SPCX) at Hold
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
